Precision Oncology Market: By Type, By End User and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Precision Oncology Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Consumable, Instruments, Services), By End User (Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, CROs) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Precision Oncology Market size was valued at US$ 49.5 billion in 2023 and is poised to grow at a CAGR of 10.1% from 2024 to 2030. Precision oncology is a cutting-edge kind of cancer therapy that makes sure your care is tailored to your particular type of cancer. It is the science of harnessing the unique genetics of each patient the genes that are mutated and cause their disease to spread to develop a personalized treatment plan based on those genetic mutations.

The global market provides a detailed overview of the market, which has been segmented by type and end-user. By type, the market has been segmented into consumable Instruments and Services. The Consumable segment is likely to be the largest and fastest-growing in terms of type. Precision oncology is segmented into Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, and CROs based on the end-user. According to precision business insights, the Diagnostic Companies segment is predicted to register the fastest growth rate during the forecast period.

Key Development

  • In July 2019, Pfizer collaborated with Syapse to advance cancer research. This collaboration was aimed to focus on molecular testing and therapy choices in precision oncology, thereby expanding the product portfolio.

summary download arrow Download Free Sample

Precision Oncology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10.1%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Precision Oncology Market Dynamics

Precision medicine combines molecular biology and system biology and is a new cancer treatment and prevention approach. Oncology precision medicine has emerged as potentially transformational, promising more excellent treatment outcomes for all cancer patients.

Precision Oncology Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 49.5 billion

Market CAGR

10.1%

By Type

  • Consumable
  • Instruments
  • Services

By End User

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Diagnostic Companies
  • CROs

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America and
  • Middle East and Africa

Key Features of the Report

  • The precision oncology market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global precision oncology market size was valued at US$ 49.5 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024-2030.

The major global precision oncology market players are Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc., NeoGenomics, QIAGEN, and Tepnel Pharma Services.

North America is the fastest-growing region for  precision oncology market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Precision Oncology Market Introduction
2.1. Global Precision Oncology Market Taxonomy
2.2. Global Precision Oncology Market Definitions
2.2.1. By End-user
2.2.2. By Type
3. Global Precision Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Precision Oncology Market Dynamic Factors - Impact Analysis
3.6. Global Precision Oncology Market Competition Landscape
4. Global Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Precision Oncology Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Pharmaceuticals Companies
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Biotechnology Companies
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Diagnostic Companies
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. CROs
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Precision Oncology Market Forecast, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Consumable
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Instruments
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Precision Oncology Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Region, 2024 - 2030
8. North America Precision OncologyMarketAnalysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Pharmaceuticals Companies
8.1.2. Biotechnology Companies
8.1.3. Diagnostic Companies
8.1.4. CROs
8.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Consumable
8.2.2. Instruments
8.2.3. Services
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country, 2024 - 2030
8.5. North America Precision Oncology Market Dynamics Trends
9. Europe Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Pharmaceuticals Companies
9.1.2. Biotechnology Companies
9.1.3. Diagnostic Companies
9.1.4. CROs
9.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Consumable
9.2.2. Instruments
9.2.3. Services
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030
9.5. Europe Precision Oncology Market Dynamics Trends
10. Asia-Pacific Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Pharmaceuticals Companies
10.1.2. Biotechnology Companies
10.1.3. Diagnostic Companies
10.1.4. CROs
10.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Consumable
10.2.2. Instruments
10.2.3. Services
10.3. Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030
10.5. Asia-Pacific Precision Oncology Market Dynamics Trends
11. Latin America Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Pharmaceuticals Companies
11.1.2. Biotechnology Companies
11.1.3. Diagnostic Companies
11.1.4. CROs
11.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Consumable
11.2.2. Instruments
11.2.3. Services
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030
11.5. Latin America Precision Oncology Market Dynamics Trends
12. Middle East and Africa Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Pharmaceuticals Companies
12.1.2. Biotechnology Companies
12.1.3. Diagnostic Companies
12.1.4. CROs
12.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Consumable
12.2.2. Instruments
12.2.3. Services
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030
12.5. MEA Precision Oncology Market Dynamics Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Eagle Genomics
13.2.2. ASEBIO
13.2.3. Menarini Silicon Biosystems
13.2.4. NanoString Technologies, Inc.
13.2.5. NeoGenomics
13.2.6. QIAGEN
13.2.7. Tepnel Pharma Services
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • Eagle Genomics
  • ASEBIO
  • Menarini Silicon Biosystems
  • NanoString Technologies, Inc.
  • NeoGenomics
  • QIAGEN
  • Tepnel Pharma Services

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market